Bernhard Ganss

Title: Innovations by Bernhard Ganss in Biomineralization

Introduction

Bernhard Ganss is an accomplished inventor based in Toronto, Canada. He has made significant contributions to the field of biomineralization through his innovative research and patents. His work focuses on the development of products that enhance the biological processes involved in mineralization.

Latest Patents

Ganss holds a patent for a device that includes biological agents for in vitro induction of biomineralization. This patent describes a product comprised of a collagen gel to which recombinant human Amelotin (AMTN) protein is added. The AMTN-collagen gel is applied to one side of a physiologically acceptable scaffold that has been impregnated with AMTN-free collagen gel. The resulting two-layer collagen membrane is designed to be applied to a mineralized tissue surface, such as dentin and bone. Upon immersion in simulated body fluid, the presence of AMTN triggers the formation of hydroxyapatite mineral deposits that connect with the existing mineral surface, providing physical attachment.

Career Highlights

Ganss is affiliated with the University of Toronto, where he conducts his research and develops his innovative products. His work has garnered attention for its potential applications in dental and bone regeneration.

Collaborations

Ganss collaborates with Yuichi Ikeda, contributing to the advancement of research in biomineralization and related fields.

Conclusion

Bernhard Ganss is a notable inventor whose work in biomineralization has the potential to impact various medical applications. His innovative approach to using biological agents in tissue engineering showcases the intersection of biology and technology.